GO:1900826 negative regulation of membrane depolarization during cardiac muscle cell action potential: Calcium Handling and Electrophysiology, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900826 describes any process that stops, prevents or reduces the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential.
• The term is a biological_process child of the regulation of cardiac muscle cell action potential and is dominated by calcium and potassium channel modulation.
• L-type calcium channel (CACNA1C) inactivation by membrane potential and intracellular calcium is a central mechanism.
• Beta-adrenergic and cyclic nucleotide signaling tune the slow calcium channels that shape the action potential plateau.
• Calmodulin kinase targeting to the action potential plateau regulates L-type Ca2+ current in cardiomyocytes.
• Dysregulation of this process contributes to arrhythmias, long QT syndromes, and contractile dysfunction, making it a target for CRISPR cell models.
Description
GO:1900826, negative regulation of membrane depolarization during cardiac muscle cell action potential, is a Gene Ontology biological process that captures the cellular mechanisms which stop, prevent or reduce the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential. In practical terms, this term describes the brakes on the rapid upstroke and plateau phase of the cardiac action potential, a phase driven largely by calcium and potassium conductances. Because the cardiac action potential is the electrical signal that triggers contraction, understanding how depolarization is negatively regulated is fundamental to cardiac electrophysiology and to the study of arrhythmia mechanisms. The process is not a single molecular event but an integrated outcome of ion channel gating, intracellular calcium handling, and phosphorylation-dependent modulation. Voltage clamp studies of single cardiac cells have been instrumental in dissecting these components, showing how membrane potential and intracellular calcium jointly govern calcium channel inactivation. This article synthesizes the authoritative GO definition with verified PubMed literature to provide a research-grade overview for scientists designing CRISPR-based cardiac cell models.
negative regulation of membrane depolarization during cardiac muscle cell action potential At A Glance
| GO ID | GO:1900826 |
|---|---|
| GO term | negative regulation of membrane depolarization during cardiac muscle cell action potential |
| Ontology | biological_process |
| Synonym | down regulation of membrane depolarization during cardiac muscle cell action potential; downregulation of membrane depolarization during cardiac muscle cell action potential; down-regulation of membrane depolarization during of cardiac muscle cell action potential; inhibition of membrane depolarization during cardiac muscle cell action potential |
| Major function | Reduces the frequency, rate or extent of membrane depolarization during the cardiac muscle cell action potential, primarily through modulation of calcium and potassium conductances |
| Key molecular players | L-type calcium channels (CACNA1C), calmodulin kinase, cyclic nucleotide-dependent phosphorylation pathways |
| Cellular context | Cardiac muscle cells (cardiomyocytes), particularly ventricular myocytes |
| Related disease relevance | Arrhythmias, long QT syndrome, contractile dysfunction |
What Is GO:1900826?
According to the Gene Ontology, GO:1900826 is defined as any process that stops, prevents or reduces the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential. It is a biological_process term whose synonyms include down regulation, downregulation, down-regulation and inhibition of membrane depolarization during a cardiac muscle cell action potential. The term sits within the broader regulation of cardiac muscle cell action potential and is mechanistically linked to ion channel inactivation, particularly of L-type calcium channels, and to signaling pathways that modulate the availability of depolarizing currents.
Why Is negative regulation of membrane depolarization during cardiac muscle cell action potential Important in Cell Biology?
GO:1900826 is important because the negative regulation of membrane depolarization determines the duration and shape of the cardiac action potential, which in turn controls calcium influx and the strength of contraction. When these negative regulatory mechanisms fail, cardiomyocytes can become hyperexcitable, leading to arrhythmias and impaired pump function. The term also provides a structured framework for interpreting experimental data from voltage clamp, calcium imaging, and genetic perturbation studies, helping researchers connect molecular events to tissue-level electrophysiology.
• Defines the molecular brakes on cardiac action potential depolarization, a key determinant of heart rhythm.
• L-type calcium channel inactivation by voltage and intracellular calcium is a core mechanism within this term.
• Cyclic nucleotide and phosphorylation signaling modulate the slow calcium channels that sustain depolarization.
• Calmodulin kinase targeting to the action potential plateau regulates L-type Ca2+ current.
• Dysregulation is linked to arrhythmogenesis and contractile dysfunction in cardiac disease.
• Provides a conceptual framework for interpreting voltage clamp and calcium imaging experiments.
• Guides CRISPR knockout and knock-in studies of ion channel genes in cardiomyocyte models.
• Supports drug discovery efforts targeting calcium and potassium channels in the heart.
• Helps explain how metabolic factors such as NAD and ammonia modulate papillary muscle contractility.
• Enables cross-species comparison of cardiac electrophysiology mechanisms.
What Happens During negative regulation of membrane depolarization during cardiac muscle cell action potential?
Initiation of the cardiac action potential and the need for negative regulation
In simple terms: The heart cell fires an electrical signal, and the body needs ways to keep that signal from getting out of control.
The cardiac muscle cell action potential begins with a rapid depolarization driven by sodium and calcium currents, followed by a plateau phase maintained largely by L-type calcium current. Negative regulation of this depolarization is essential to terminate the plateau and allow repolarization. Voltage clamp studies of single ventricular cells have shown that the action potential waveform is shaped by the balance between inward and outward currents, and that negative regulation is achieved by inactivation of inward currents and activation of outward potassium currents. Calcium influx during the action potential in guinea pig ventricular myocytes has been directly measured, confirming that the plateau is sustained by calcium entry that must later be curtailed.
Voltage- and calcium-dependent inactivation of L-type calcium channels
In simple terms: The calcium channels that keep the cell depolarized shut themselves off when the voltage stays high or calcium builds up inside.
A central mechanism of negative regulation is the inactivation of L-type calcium channels, which depends jointly on membrane potential and intracellular calcium. Pietrobon and colleagues described a novel voltage-dependent gating mechanism in L-type calcium channels, providing a molecular basis for how these channels can reduce depolarizing current. In mammalian heart cells, inactivation of calcium channels is not a simple on-off switch but a joint function of voltage and calcium, allowing fine-tuning of the action potential duration. This inactivation directly reduces the frequency and extent of membrane depolarization, matching the GO:1900826 definition.
Phosphorylation and cyclic nucleotide modulation of slow calcium channels
In simple terms: Chemical tags added by signaling molecules can change how long the calcium channels stay open, tuning the heartbeat.
Sperelakis reviewed how cyclic nucleotides and phosphorylation regulate calcium slow channels of cardiac muscle, showing that beta-adrenergic stimulation can enhance calcium current while dephosphorylation reduces it. This phosphorylation-dependent modulation is a key layer of negative regulation: when kinase activity is low or phosphatase activity is high, the slow calcium channels carry less current, reducing depolarization. Wu and colleagues demonstrated that calmodulin kinase is functionally targeted to the action potential plateau for regulation of L-type Ca2+ current in rabbit cardiomyocytes, linking a specific kinase to the timing of depolarization. These findings establish that negative regulation is not purely biophysical but also biochemical.
Contribution of potassium channels and metabolic factors
In simple terms: Other channels and even cellular metabolism can help put the brakes on the electrical signal.
Potassium channels play a major role in opposing depolarization, and their function is critical for repolarization and for limiting the duration of the action potential. Averin and colleagues showed that NAD and ammonia interplay regulates papillary muscle contractility through ion channels and exchangers, indicating that metabolic state can influence the negative regulation of depolarization. Although the exact contribution of each potassium conductance varies by species and region, the principle that outward potassium currents counteract inward calcium currents is well established.
Key Genes Involved in GO:1900826 negative regulation of membrane depolarization during cardiac muscle cell action potential
The following genes and proteins are mechanistically linked to the negative regulation of membrane depolarization during the cardiac muscle cell action potential, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CACNA1C | Encodes the pore-forming alpha-1C subunit of the L-type calcium channel; its inactivation reduces depolarizing current | Target for knockout or point mutation to study calcium-dependent inactivation |
| CALM1 | Calmodulin binds calcium and modulates L-type calcium channel activity | Knock-in of calmodulin mutations to test calcium sensing |
| CAMK2D | Calmodulin kinase II delta; targeted to the action potential plateau to regulate L-type Ca2+ current | Knockout or kinase-dead knock-in to dissect phosphorylation effects |
| PRKACA | Catalytic subunit of protein kinase A; mediates cyclic nucleotide-dependent phosphorylation of calcium channels | Overexpression or knockout to test beta-adrenergic modulation |
| PRKACB | Another catalytic subunit of protein kinase A involved in cardiac phosphorylation | CRISPR models to study isoform-specific effects |
| KCNQ1 | Potassium channel alpha subunit contributing to repolarization and opposing depolarization | Knockout to assess loss of negative regulation |
| KCNH2 | Potassium channel underlying rapid delayed rectifier current, important for repolarization | Point mutations linked to long QT syndrome |
| KCNJ2 | Inward rectifier potassium channel that stabilizes resting potential and opposes depolarization | Knock-in of disease mutations |
| SCN5A | Sodium channel responsible for the rapid upstroke; its inactivation contributes to negative regulation | Knockout or knock-in to study inactivation gating |
| ATP1A1 | Na+/K+-ATPase maintains ionic gradients required for repolarization | Overexpression to test metabolic modulation |
| SLC8A1 | Sodium-calcium exchanger that removes calcium and influences depolarization | Knockout to study calcium handling |
| NPPA | Natruretic peptide precursor A; marker of cardiac stress and hypertrophy | Overexpression to model pathological remodeling |
| MYH7 | Beta-myosin heavy chain; contractile protein whose function depends on action potential-driven calcium | Knock-in of hypertrophic cardiomyopathy mutations |
| TNNT2 | Troponin T2; calcium-sensitive regulator of contraction downstream of depolarization | Point mutation to study contractile coupling |
| RYR2 | Ryanodine receptor 2; releases calcium from sarcoplasmic reticulum, influencing depolarization | Knock-in of arrhythmogenic mutations |
| ATP2A2 | SERCA2 calcium pump; clears cytosolic calcium and affects action potential duration | Overexpression to enhance calcium reuptake |
How Is negative regulation of membrane depolarization during cardiac muscle cell action potential Regulated?
The negative regulation of membrane depolarization during the cardiac muscle cell action potential is itself regulated by multiple signaling pathways. Cyclic nucleotide signaling, particularly through protein kinase A, modulates the phosphorylation state of calcium slow channels, thereby altering the availability of depolarizing current. Calmodulin kinase is functionally targeted to the action potential plateau, providing a calcium-dependent feedback mechanism that tunes L-type Ca2+ current. In addition, metabolic factors such as NAD and ammonia can influence ion channels and exchangers, indirectly affecting the negative regulation of depolarization. Potassium channel activity, which opposes depolarization, is also subject to regulation by various intracellular signals. Together, these pathways form a layered control system that ensures the action potential terminates appropriately.
negative regulation of membrane depolarization during cardiac muscle cell action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNH2 | Long QT syndrome, arrhythmia | Knock-in of patient mutations in cardiomyocytes |
| SCN5A | Brugada syndrome, conduction disease | Knockout or point mutation to study inactivation |
| CACNA1C | Timothy syndrome, arrhythmia | Point mutation knock-in to alter inactivation gating |
| RYR2 | Catecholaminergic polymorphic ventricular tachycardia | Knock-in of arrhythmogenic mutations |
| ATP2A2 | Heart failure, contractile dysfunction | Overexpression to enhance calcium reuptake |
Arrhythmias and long QT syndrome
Impaired negative regulation of membrane depolarization can prolong the action potential and predispose to early afterdepolarizations, a hallmark of long QT syndrome and other arrhythmias. Mutations in potassium channels such as KCNH2 or KCNQ1 reduce outward currents that normally oppose depolarization, leading to delayed repolarization. Similarly, dysfunction of L-type calcium channel inactivation can sustain depolarization and trigger arrhythmogenic activity.
Heart failure and contractile dysfunction
In heart failure, changes in calcium handling and ion channel expression alter the action potential waveform and the negative regulation of depolarization. Reduced calcium reuptake by SERCA2 or increased Ryanodine receptor leak can disturb the balance of inward and outward currents, contributing to contractile dysfunction. Metabolic perturbations, such as altered NAD and ammonia levels, have been shown to affect papillary muscle contractility through ion channels and exchangers, linking metabolic state to electrical dysfunction.
Hypertension and vascular tone
Potassium channels play a critical role in vascular tone regulation and hypertension, and their dysfunction can indirectly affect cardiac workload and action potential dynamics. While the primary focus of GO:1900826 is the cardiomyocyte, systemic factors such as hypertension can remodel ion channel expression and exacerbate abnormalities in depolarization regulation.
From negative regulation of membrane depolarization during cardiac muscle cell action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CACNA1C alter action potential duration? | CRISPR knockout of CACNA1C in cardiomyocytes |
| How does a specific calmodulin mutation affect L-type calcium current? | Point mutation knock-in of CALM1 |
| Can overexpression of SERCA2 rescue contractile dysfunction? | Overexpression of ATP2A2 in heart failure models |
| What is the role of CAMK2D phosphorylation in plateau regulation? | Kinase-dead knock-in of CAMK2D |
| Does a potassium channel mutation cause long QT? | Knock-in of KCNH2 mutation in iPSC-derived cardiomyocytes |
| How does metabolic stress affect depolarization? | Knockout of ATP1A1 combined with NAD/ammonia treatment |
How to Study the negative regulation of membrane depolarization during cardiac muscle cell action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Voltage clamp | Ionic currents underlying action potential | Quantify calcium and potassium current inactivation |
| Calcium imaging | Intracellular calcium transients | Assess calcium-dependent inactivation |
| Western blot | Protein phosphorylation levels | Measure cyclic nucleotide-dependent modulation |
| Kinase assay | Enzymatic activity of CAMK2D or PKA | Test phosphorylation of calcium channels |
| Patch-seq | Transcriptome and electrophysiology of single cells | Correlate gene expression with action potential phenotype |
| CRISPR knockout | Loss-of-function phenotype | Test necessity of a gene in negative regulation |
| CRISPR knock-in | Mutant protein function | Model disease-associated point mutations |
Voltage clamp electrophysiology
Single-cell voltage clamp is the gold-standard method for measuring the ionic currents that underlie the cardiac action potential and its negative regulation. By controlling membrane potential, researchers can isolate calcium and potassium currents and quantify how genetic perturbations alter inactivation kinetics.
Calcium imaging and photometry
Calcium imaging with fluorescent indicators allows direct measurement of intracellular calcium transients during the action potential, providing insight into the calcium-dependent component of negative regulation. This method is particularly useful for linking channel inactivation to changes in contractility.
Phosphorylation and signaling assays
Western blotting and kinase activity assays can quantify the phosphorylation state of calcium channels and associated proteins, revealing how cyclic nucleotide pathways modulate depolarization. Calmodulin kinase targeting can be assessed by co-immunoprecipitation and substrate phosphorylation.
CRISPR-based genetic perturbation
CRISPR knockout, knock-in, and overexpression models enable causal testing of specific genes in the negative regulation of depolarization. These approaches can be combined with electrophysiology and imaging to connect genotype to phenotype.
How CRISPR Can Be Used to Study GO:1900826 negative regulation of membrane depolarization during cardiac muscle cell action potential
Knockout
CRISPR knockout of genes such as CACNA1C, KCNH2, or CAMK2D can reveal their essential roles in the negative regulation of membrane depolarization. Loss-of-function models allow researchers to measure changes in action potential duration and calcium handling, providing causal evidence for gene function.
Point Mutation
Point mutation knock-in is used to model disease-associated variants in ion channel genes, such as KCNH2 or SCN5A, that alter inactivation gating and impair negative regulation. These models help dissect the precise biophysical consequences of single amino acid changes.
Knock-in
Knock-in of reporter tags or disease mutations allows tracking of channel localization and function in cardiomyocytes. For example, tagging CACNA1C with a fluorescent protein enables live-cell imaging of channel trafficking and its impact on depolarization.
Overexpression
Overexpression of genes such as ATP2A2 (SERCA2) or PRKACA can enhance or disrupt negative regulation, providing gain-of-function models to test sufficiency. These models are valuable for studying how increased calcium reuptake or phosphorylation affects action potential duration.
How EDITGENE Supports negative regulation of membrane depolarization during cardiac muscle cell action potential Research
Researchers studying negative regulation of membrane depolarization during cardiac muscle cell action potential-related genes often need to determine whether a candidate gene is causally involved in shaping the action potential or is merely a bystander. EDITGENE provides the CRISPR tools and cell models required to move from correlation to causation in cardiac electrophysiology.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of membrane depolarization during cardiac muscle cell action potential research.
Frequently Asked Questions About negative regulation of membrane depolarization during cardiac muscle cell action potential
What is GO:1900826?
GO:1900826 is a Gene Ontology biological process term defined as any process that stops, prevents or reduces the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential.
What genes are involved in negative regulation of membrane depolarization during cardiac muscle cell action potential?
Key genes include CACNA1C, CALM1, CAMK2D, PRKACA, KCNQ1, KCNH2, and SCN5A, based on their roles in calcium and potassium channel function.
How does calcium channel inactivation contribute to this process?
L-type calcium channel inactivation depends jointly on membrane potential and intracellular calcium, reducing the depolarizing current that sustains the action potential plateau.
What is the role of phosphorylation in regulating cardiac depolarization?
Cyclic nucleotide-dependent phosphorylation modulates slow calcium channels, altering the availability of depolarizing current and thus the action potential duration.
Which diseases are linked to impaired negative regulation of cardiac depolarization?
Arrhythmias, long QT syndrome, heart failure, and contractile dysfunction are associated with disrupted regulation of cardiac depolarization.
How can CRISPR be used to study GO:1900826?
CRISPR knockout, knock-in, and overexpression models allow causal testing of specific genes in cardiomyocytes, combined with voltage clamp and calcium imaging to measure effects on depolarization.
What methods measure membrane depolarization in cardiomyocytes?
Voltage clamp electrophysiology and calcium imaging are standard methods for measuring the ionic currents and calcium transients that underlie depolarization.
Is calmodulin kinase involved in the action potential plateau?
Yes, calmodulin kinase is functionally targeted to the action potential plateau to regulate L-type Ca2+ current in rabbit cardiomyocytes.
What is the difference between depolarization and repolarization?
Depolarization is the rise in membrane potential that triggers contraction, while repolarization is the return to resting potential; negative regulation of depolarization limits the extent of the rise.
How do potassium channels oppose depolarization?
Potassium channels carry outward currents that counteract inward calcium and sodium currents, helping to terminate the action potential and limit depolarization.
Conclusion
GO:1900826 provides a precise ontological framework for the molecular brakes on cardiac muscle cell depolarization. The process is governed by calcium channel inactivation, phosphorylation-dependent modulation, and potassium conductances, with clear implications for arrhythmias and heart failure. CRISPR-based cell models offer a powerful way to dissect these mechanisms and identify new therapeutic targets.
References
- 1. Sperelakis N. 1988. Regulation of calcium slow channels of cardiac muscle by cyclic nucleotides and phosphorylation.. J Mol Cell Cardiol 20 Suppl 2:75-105 PMID: 2457707
- 2. Varró A et al.. 1992. The impact of single cell voltage clamp on the understanding of the cardiac ventricular action potential.. Cardioscience 3(3):131-44 PMID: 1384746
- 3. Averin AS et al.. 2022. Regulation of Papillary Muscle Contractility by NAD and Ammonia Interplay: Contribution of Ion Channels and Exchangers.. Membranes (Basel) 12(12) PMID: 36557146
- 4. Madiwila Gamarachchige T et al.. 2026. Role of Potassium Ion Channels in Vascular Tone Regulation and Hypertension.. Arterioscler Thromb Vasc Biol 46(6):e324059 PMID: 41988716
- 5. Grantham CJ et al.. 1996. Ca2+ influx during the cardiac action potential in guinea pig ventricular myocytes.. Circ Res 79(2):194-200 PMID: 8755995
- 6. Pietrobon D et al.. 1990. Novel mechanism of voltage-dependent gating in L-type calcium channels.. Nature 346(6285):651-5 PMID: 2166917
- 7. Wu Y et al.. 2004. Calmodulin kinase is functionally targeted to the action potential plateau for regulation of L-type Ca2+ current in rabbit cardiomyocytes.. J Physiol 554(Pt 1):145-55 PMID: 14678498
- 8. Lee KS et al.. 1985. Inactivation of calcium channels in mammalian heart cells: joint dependence on membrane potential and intracellular calcium.. J Physiol 364:395-411 PMID: 2411919
